Biofrontera Inc Share Price Today: Live Updates & Key Insights

Biofrontera Inc share price today is $0.8472, up 1.68%. The stock opened at $0.821 against the previous close of $0.8556, with an intraday high of $0.8599 and low of $0.805.

Biofrontera Inc Share Price Chart

Biofrontera Inc

us-stock
To Invest in {{usstockname}}
us-stock

Biofrontera Inc Share Price Performance

$0.8472 0.0168(1.68%) BFRI at 23 Mar 2026 12:11 PM Drug Manufacturers - Specialty & Generic
Lowest Today 0.805
Highest Today 0.8599
Today’s Open 0.821
Prev. Close 0.8556
52 Week High 1.19
52 Week Low 0.54
Day’s Range: Low 0.805 High 0.8599
52-Week Range: Low 0.54 High 1.19
1 day return -
1 Week return -0.32
1 month return -3.29
3 month return +20.61
6 month return -14.13
1 year return -5.34
3 year return -92.71
5 year return -99.04
10 year return -

Biofrontera Inc Institutional Holdings

Rosalind Advisors, Inc. 9.79

AIGH Capital Management, LLC 7.86

Vanguard Group Inc 0.98

Geode Capital Management, LLC 0.56

Fidelity Extended Market Index 0.47

Vanguard Institutional Extnd Mkt Idx Tr 0.45

Jane Street Group LLC 0.28

XTX Topco Ltd 0.15

TWO SIGMA SECURITIES, LLC 0.12

Susquehanna International Group, LLP 0.10

Sanctuary Advisors, LLC 0.09

Fidelity Series Total Market Index 0.06

Citigroup Inc 0.05

BlackRock Inc 0.04

Spartan Total Market Index Pool G 0.02

UBS Group AG 0.01

NT Ext Equity Mkt Idx Fd - NL 0.01

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

Fidelity Total Market Index 0.00

Northern Trust Extended Eq Market Idx 0.00

NT Ext Equity Mkt Idx Fd - L 0.00

SBI Securities Co Ltd 0.00

Spartan Extended Market Index Pool F 0.00

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

State St US Extended Mkt Indx NL Cl C 0.00

Bank of America Corp 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

SSgA U.S. Total Market Index Strategy 0.00

Blackrock Extended Mkt Fund CF 0.00

Blackstone Alternative Multi-Strategy I 0.00

Extended Equity Market Fund K 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

HRT FINANCIAL LLC 0.00

Hunter Associates Inc. 0.00

Renaissance Technologies Corp 0.00

Virtu Financial LLC 0.00

Biofrontera Inc Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Biofrontera Inc Fundamentals

Market Cap 10.12 M

PB Ratio 0.6503

PE Ratio 0.0

Enterprise Value 11.35 M

Total Assets 28.56 M

Volume 192517

Biofrontera Inc Company Financials

Annual Revenue FY23:33619000 33.6M, FY22:28674000 28.7M, FY21:24100000 24.1M, FY20:18849000 18.8M, FY19:26181000 26.2M

Annual Profit FY23:16287000 16.3M, FY22:13489000 13.5M, FY21:11358000 11.4M, FY20:9783000 9.8M, FY19:13773000 13.8M

Annual Net worth FY23:-26442000 -26.4M, FY22:-640000 -0.6M, FY21:-37713000 -37.7M, FY20:-10987000 -11.0M, FY19:-10982000 -11.0M

Quarterly Revenue Q3/2025:6988000 7.0M, Q2/2025:9030000 9.0M, Q1/2025:8588000 8.6M, Q3/2024:9012000 9.0M, Q2/2024:7839000 7.8M

Quarterly Profit Q3/2025:5066000 5.1M, Q2/2025:6650000 6.7M, Q1/2025:5513000 5.5M, Q3/2024:4135000 4.1M, Q2/2024:3497000 3.5M

Quarterly Net worth Q3/2025:-6649000 -6.6M, Q2/2025:-5324000 -5.3M, Q1/2025:-4203000 -4.2M, Q3/2024:-5669000 -5.7M, Q2/2024:-257000 -0.3M

About Biofrontera Inc & investment objective

Company Information Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Organisation Drug Manufacturers - Specialty & Generic

Employees 92

Industry Drug Manufacturers - Specialty & Generic

CEO Dr. Hermann Luebbert Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Biofrontera Inc FAQs

What is the share price of Biofrontera Inc today?

The current share price of Biofrontera Inc is $0.8472.

Can I buy Biofrontera Inc shares in India?

Yes, Indian investors can buy Biofrontera Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Biofrontera Inc shares in India?

You can easily invest in Biofrontera Inc shares from India by:

Can I buy fractional shares of Biofrontera Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Biofrontera Inc?

Biofrontera Inc has a market cap of $10.12 M.

In which sector does Biofrontera Inc belong?

Biofrontera Inc operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Biofrontera Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Biofrontera Inc?

The PE ratio of Biofrontera Inc is N/A and the PB ratio is 0.65.